Clinical News

Dupilumab-Induced Psoriasiform Lesions Reported in Pediatric Patients

1 hour ago

By Armand Butera

Investigators recommended a treatment course of at least 1-2 months with medium strength to potent topical corticosteroids should be considered before dupilumab discontinuation in affected children and adolescents.

FDA Approves Port Delivery System with Ranibizumab for Wet AMD

2 hours ago

By Kevin Kunzmann

The novel PDS implant will allow patients with retina disease to receive continuous anti-VEGF formulation for up to 6 months between refills.

Diabetic Medicine Intensification May Not Benefit Older Adults After Hospitalization

3 hours ago

By Connor Iapoce

In older patients receiving medication intensification, no differences were seen in the risk of severe hyperglycemia, severe hypoglycemia, or death at 1 year.

Medium-Dose Ultraviolet A1 Cold Light Preferred Atopic Dermatitis Treatment

5 hours ago

By Armand Butera

Though high-dose ultraviolet therapy was also effective, investigators were concerned with the potential long-term adverse events.

Dupilumab Meets Endpoints in Phase 3 Study of Prurigo Nodularis

7 hours ago

By Armand Butera

This represents the first biologic to show positive phase 3 results in prurigo nodularis.

ALA Discusses Severe Asthma Biologics with Mario Castro, MD, MPH

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.

The Rare Disease Report Podcast: Niemann-Pick Disease

Listen to an expert discuss the heterogenous, and potentially fatal, lysosomal storage disorder.

John E. Harris, MD, PhD: The Current State of Vitiligo and Alopecia Areata Research

The vitiligo expert discusses new tactics and therapeutic options in treating inflammatory skin disorders like vitiligo, alopecia areata, and atopic dermatitis.

New Heart Failure Data from ESC 2021 with Marat Fudim, MD

Manesh Patel, MD, kicks off his first podcast by discussing HFpEF findings in EMPEROR-Preserved, the GUIDE-HF trial and more with his Duke colleague.

Coping After COVID: Challenging Circumstances for ADHD Patients

On this episode of Coping After COVID, Dr. Yamalis Diaz explained just how challenging this year has been for patients with ADHD.

Crisis Point - Obesity Crisis

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

Conference Coverage

View All >>

Pursuing Tailored Care for Diabetic Macular Edema

October 13, 2021

By Kevin Kunzmann

The retina field is equipped with ideal therapy and research informing implementation. Now it needs greater patient buy-in.

Intravitreal Injections Linked to Psychosocial Burden in Retina Disease Patients

October 13, 2021

By Kevin Kunzmann

Assessment from a patient survey showed an association between increased rates of injection treatment and increased restriction on usual activity for patients.

Factors Influencing Treatment of Diabetic Macular Edema

October 13, 2021

By Kevin Kunzmann

Rishi P. Singh, MD, discusses new VISTA/VIVID data showing what really influences a patients' likelihood and time to DME resolution when treated with aflibercept.